Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Eton Pharmaceuticals Inc (ETON)
Eton Pharmaceuticals Inc (ETON) Actualités

Eton Pharmaceuticals Inc (ETON)

36,625

-0,705

( -1,89% )

Mis à jour : 19:20:59

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)

IMPAVIDO® is the first and only FDA-approved oral therapy for visceral, cutaneous, and mucosal leishmaniasis...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Eton Pharmaceuticals

UBS Irl Fund Solutions

Whitehorse Gold

First Trust Technology A...

Anheuser Busch Inbev SA NV

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.